Canada markets closed

Vivoryon Therapeutics N.V. (05Y.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.7830+0.0770 (+10.91%)
At close: 12:18PM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 19.76M
Enterprise Value -8.79M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)26.02
Price/Book (mrq)0.70
Enterprise Value/Revenue 2.43
Enterprise Value/EBITDA 0.31

Trading Information

Stock Price History

Beta (5Y Monthly) 1.27
52-Week Change 3-95.98%
S&P500 52-Week Change 322.38%
52 Week High 319.5000
52 Week Low 30.4000
50-Day Moving Average 31.7257
200-Day Moving Average 37.6028

Share Statistics

Avg Vol (3 month) 340.22k
Avg Vol (10 day) 335.82k
Shares Outstanding 525.96M
Implied Shares Outstanding 626.11M
Float 820.18M
% Held by Insiders 125.56%
% Held by Institutions 135.57%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)484.67%

Management Effectiveness

Return on Assets (ttm)-56.74%
Return on Equity (ttm)-107.38%

Income Statement

Revenue (ttm)-3.62M
Revenue Per Share (ttm)-0.14
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -28.07M
Net Income Avi to Common (ttm)-28.34M
Diluted EPS (ttm)-1.2400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)28.73M
Total Cash Per Share (mrq)1.16
Total Debt (mrq)38k
Total Debt/Equity (mrq)0.14%
Current Ratio (mrq)9.37
Book Value Per Share (mrq)1.07

Cash Flow Statement

Operating Cash Flow (ttm)-21.54M
Levered Free Cash Flow (ttm)-11.32M